Bronchoalveolar Results in Young Children with Chronic Lung Symptoms: Lessons Learned from an Allergy–Pulmonology Project Guided by an Updated Mini Review of the Current Literature of Bronchoalveolar Lavage Eosinophilia and Neutrophilia in Normal Children
Russell J. Hopp, Elizabeth A. Eischeid, Steven Rose, Heather Thomas

TL;DR
This study updates normal bronchoalveolar lavage (BAL) cell counts in children and finds that elevated eosinophils and neutrophils are common in symptomatic children, suggesting asthma or protracted bronchitis.
Contribution
The study provides an updated reference for BAL cellularity in normal children and highlights new insights into interpreting abnormal results in symptomatic cases.
Findings
Eosinophils >1 were found in up to 25% of children with asthma-like symptoms and a similar percentage in non-asthma cases.
Neutrophilia >50% and high bacterial colony counts were common in over 50% of children undergoing BAL.
Lipid-laden macrophages were not specific to aspiration-related diagnoses.
Abstract
What are the main findings of this study? The background of BAL cellularity in normal children has not been updated for more than 25 years, which can serve as a reference point for comparing results in symptomatic childrenBronchoalveolar lavage (BAL) in young children is usually done under circumstances of complex pulmonary symptomatology and comparing their results with normal children can be revealing. The background of BAL cellularity in normal children has not been updated for more than 25 years, which can serve as a reference point for comparing results in symptomatic children Bronchoalveolar lavage (BAL) in young children is usually done under circumstances of complex pulmonary symptomatology and comparing their results with normal children can be revealing. What are the implications of the main findings? Eosinophilia is not expected in the lavage fluid of normal children, so…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAsthma and respiratory diseases · Respiratory and Cough-Related Research · Tracheal and airway disorders
1. Introduction
Bronchoalveolar lavage (BAL) findings are rarely in the purview of allergy immunologists, while pediatric pulmonologists perform the procedure on a routine basis. The information gained with cytology and bacteriologic analysis is valuable for current and future clinical care [1,2]. In a unique situation where allergy and pulmonary co-inhabit a divisional structure, the review of BAL results is a frequent conversation in clinical care conferences. An interesting historical perspective reviewing the utility of bronchoscopy in severe pediatric asthma is available [3].
Eosinophilia is considered a common denominator in both allergic and asthmatic states [4], and peripheral eosinophilia is considered a risk factor in the Modified Asthma Predictive Index (mAPI) [5]. The mAPI and the Pediatric Asthma Risk Score (PARS) use clinical data to predict asthma in young children, including peripheral eosinophilia [5,6].
Pulmonary function testing is not generally available until age four or older and forced impulse oscillometry is rarely available. Exhaled nitric oxide is often under-compensated, so it is often limited in clinical practices by financial constraints and is difficult for younger children to perform. Thus, children in the pre-school range often have minimal and/or age-limited objective data of asthma assessment. If, in a young child, objective BAL cellularity is available, its information may be the only objective data for clinical decision making.
Our mini review of BAL data in control children since 1994 showed that virtually no eosinophils and minimal neutrophils should be seen in the cellular differential, and by inference the bacteriological presence would be negative in those same control children (Table 1) [1,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26]. The presence of an eosinophil(s) or exaggerated neutrophils provides definite clinical context as they are not expected as normal lavage resident cells [1,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26].
As a sub-analysis of the student research project, we analyzed five years of BAL results from an academic pediatric medical center, using the lavage cellularity and bacteriological results in children six years and less. The results were reviewed by a pulmonologist and an allergist, to provide a unique multi-experiential dimensional perspective on the data. We present here the results and conclusions drawn from a collaborative study undertaken by the allergy and pulmonary academic division to compare the results of an exploratory sample of BAL cellularity in complex pulmonary-symptomatic children and their results compared to the results of our literature mini review of the expected cellularity findings in normal children. We sought to provide evidence that neither eosinophils or neutrophils are expected to be recovered cellular constituents in pediatric pulmonary lavage.
2. Methods
The mini review for establishing the expected reference differential BAL cell counts in normal (control) children was completed using Undermind (www.undermind.ai. 1111B South Governors Avenue, Suite 3611, Dover, DE 19904, USA), an AI-powered research assistant, followed by a Pub-Med cross-check, using the same search terms for both: pediatric, healthy, controls, and BAL cellular norms, focusing on English language as a priority. The discovered manuscripts were searched for references undiscovered by the two search strategies. The results were then used to compare the findings seen in a sample population of children in an academic medical center by a group of pulmonologists in an allergy–pulmonary division. The overriding premise of the protocol was that neither eosinophilia nor neutrophilia should be present in a lavage, and how the outcomes of the lavage data should trigger further investigation.
The protocol was initiated as part of a summer undergraduate research project sponsored by University of Nebraska Medical Center (UNMC) and Child Health Research Institute (CHRI) at Children’s Nebraska (1 June 2025 to 30 August 2025). The student (EE) was sponsored by an author (pulmonologist), and the project approved by the Institutional Review Board at UNMC # 309-25-EP, with an approval start date of 25 June 2025. The data was de-identified for name and address. Age was included for statistical analysis. Gender was not used in the analysis. Race and/or ethnicity was provided but not used in the analysis. The IRB allowed data extraction for the operative (BAL) day only based on a provided medical record number. The analysis supervisor (allergist) was blinded to all identifiers.
Since this post hoc protocol limited the investigators by the IRB to the information provided on the operative day diagnosis, there was no allowance for chart surveillance for asthma medication, antibiotics, or esophageal reflux medications. The protocol was limited to the day of lavage diagnosis, and both the pre- and/or post-lavage diagnoses. The lavage data was separately extracted and then stratified by the group operative day diagnoses.
The IRB allowed 500 pediatric patients with the inclusion dates of 2000–2024. The analysis in this report was limited to 0–6 years of age to focus on children who had a BAL for a multitude of medical concerns, including asthma, bronchitis, aspiration, chronic cough, or similar chronic issues. After the 500 children were provided by the medical records department from 1 January 2000 to the stop date of 31 December 2024, the students reviewed and extracted from the medical record the BAL operative day diagnosis(es), the age, lavage cellularity, Lipid Index, cultures and organism(s) recovered. The IRB excluded a detailed chart review for all other laboratory, radiological medication, and non-BAL pulmonary assessment (i.e., PFT). For this analysis 317 children, 0–6 years, are included. The BAL was performed by the Pediatric Pulmonary faculty at Children’s Nebraska. None of the subjects were co-managed by the allergist (RJH).
Briefly, the BAL procedure followed established guidelines [1]. The cytology, culture, and Lipid-Laden Macrophage (LLM) Index were performed using standard laboratory procedure.
3. Statistical Methods
Mean age and differences in age among the children were determined using t-test with p < 0.05 considered significant. Determination of differences in eosinophils, neutrophils, culture and lipid-laden macrophages was by a chi-square analysis with a p value < 0.05 considered significant.
4. Results
The last review of lavage cellularity had been a five-study report in 1995. To expand the database of normal/control children with lavage results we searched the discoverable results of normal/control children for BAL cytology after 1995 through the current literature. Table 1 shows the results of eighteen studies with reported cell counts, and five opinion publications which also referenced the discovered manuscripts and/or speculated on the likely recoverability of cells in lavage fluid. Based on the results of our mini review of existing studies we choose an eosinophil count of one or more as a relevant eosinophil number (count), and 50% or more of neutrophils (of the percent of 100 cells) as a conservative indicator of an inflammatory component to the lavage. Colony counts > 100,000 organisms were the usual cut-off for the pulmonologist doing the lavage at our institution and were kept as significant results. The mini review could also serve as a reference for all pediatric bronchoscopists as the data has multiple international sources.
For our exploratory sample three-hundred seventeen children were included from the larger population defined by the protocol. The BAL operative diagnosis could include two or more relevant pulmonary concerns (i.e., asthma and chronic cough), so the analysis investigated overlapping possibilities. The IRB limited our access to the chart for each subject enrolled, so the data extracted from the operative day report submitted by the pulmonologist was the only available result and limited us to a descriptive analysis of the information from the operative report diagnoses and the lavage data.
In the overall group, the mean age was 2.0 +/− 1.41 years. Racial/ethnic identity was collected but not utilized in the analysis. It was thought there was no influence of the ethnicity of the subjects in the analysis. Sixty-six percent of the children were male. There were no significant age differences between the groups defined by the BAL diagnoses (Table 2).
The BAL-day diagnostic likelihood(s) are presented in Table 2, along with the eosinophils (% per 100 cells) recovered in each group and sub-group. Group 1 had a pre-BAL diagnosis of asthma, while Group 2 were the remaining children without an asthma pre-diagnosis. Group 2 was then distributed into Groups 3–6 for further stratification (at least one of the diagnoses listed but not asthma) for an analysis. However, Group 6 had no asthma, and none of the other listed diagnoses.
Groups 3–5 could have more than one diagnosis, so the total n is >178 (no asthma) and is not discrete. If aspiration was a concern, the information for barium swallow or reflux medication was not permitted to be extracted but could be information known to the pulmonologist.
Using eosinophilia as critical element of cellularity of the lavage fluid, one or more eosinophils were seen in 28% of children with an asthma concern at BAL; meanwhile, in the non-asthmatic group and the different non-asthmatic groups a 20% recoverability of one eosinophil or more was found, but with a non-significant difference between Groups 2–6 and Group 1.
Table 3 defines the presence of percent neutrophils/per 100 cells counted in the lavage fluid. Group 1 was asthma, Group 2 the remaining children without asthma, and Groups 3–6 were the Group 2 children but further stratified and had at least one of the diagnoses listed, but not asthma. Group 6 had no asthma, and none of the other listed diagnoses. Approximately half of all BAL results revealed a 50% or greater recoverability of neutrophils.
Table 4 divides the groups into colony count ≥ 100,000 organisms with the neutrophil count 0–50%, or 50% or above (per 100 cells), or neither. There was not a significance of neutrophils tracking with a high bacterial count. Secondarily, the number of subjects with eosinophils ≥ 1 in the lavage was considered a potential variable of co-presence with neutrophils, as a potential cellular constituent that was present only based on the granulocyte load; however, eosinophilia ≥ 1 did not significantly track with elevated neutrophils (Data not shown). The groups were as previously defined.
Table 5 divides the lipid-laden macrophages (when reported) into 0–29 and 30 and above, with the aspiration subset (but no asthma) compared to the other non-aspiration groups. In fact, a LLM of 30 or higher was more commonly seen in the non-aspiration group.
5. Discussion
Bronchoalveolar lavage (BAL) is an available procedure for children with enigmatic respiratory problems, and the technical aspects and utilization concepts have been previously published [1,2,3]. Control children’s BAL cell count differential data for comparison is not limited, but recent reviews on normal or control children are less available, and our review extends the data through 2023. (Table 1) For comparison, a 1990 American Thoracic Society Steering Committee review of the BAL cellularity of nineteen studies with five to seventy-eight non-smoking adults reported that neutrophils ranged from 0 to 12% and eosinophils 0 to 1% [27].
To support a priori contention that eosinophils are not expected in BAL fluid in control children, and neutrophils should be of low numbers in the lavage cellularity, a mini review of published data in normal (control), healthy children was undertaken as basis for comparison of our exploratory population. The summary data (Table 1), the largest known compilation of normal/control pediatric BAL cytology, showed eosinophils are less than 1/100 cells counted, while resident neutrophils are less than 5/100 cells (Table 1). Thus, we established a cut-off of 0 vs. ≥1 eosinophils; although using 50 neutrophils/100 cells is 10× the expected, in this population it is a reasonable cut-off regardless of the lavage rationale (diagnosis), as neutrophilia was a common finding, and a cut-off needed to be established.
The second purpose of this report was to provide a report of the data obtained during a diagnostic BAL, comparing the operative report diagnosis to the objective results obtained at the BAL. An asthma possibility was not the only reason for the lavage but served as a convenient anchor point in the presentation of the 317 children with distinct reasons for their intervention. All children had complex pulmonary conditions, and the information obtained could be useful prospectively for the child receiving the lavage, but also as an object lesson in interpreting pediatric BAL information.
Our retrospective evaluation of BAL cytology in 317 children aged 0–6 years in our exploratory group who had underwent bronchoscopy for a variety of complex lung symptoms revealed a markedly different pattern of cellular presence than found in healthy children (Table 2). Macrophages were 1/3 of what is expected, largely replaced by neutrophils. Eosinophils were frequently recovered, even in children without a pre-procedure diagnosis of asthma. These findings coupled with culture results proved valuable for the pulmonologists performing the BAL and caring for the child. The post hoc comments by the allergy component of the project provides additional insights. It also suggests a pre-BAL checklist of the clinical status/medications (inhaled steroids) would be valuable, and that eosinophils should be reported on each cytology read-out as cells(s)/100 count.
Asthma, both allergic and non-allergic forms, is an eosinophil-associated disease [3]. Eosinophils are not always recovered from pediatric asthma BAL, but these children are often severe cases and are likely on asthma therapy for their disease [28]. Thus, eosinophils are expected but not universally recoverable in an asthmatic lavage. Much of the literature on young children with asthma symptoms is most often reported as having recurrent wheeze or chronic cough in published data [29]; meanwhile, in more recent BAL in children with asthma virtually all have severe disease and have potential medication interactions with cellularity findings (i.e., corticosteroids) [30]. Several publications in the pulmonary or allergy journals in the past 25 years reported lavage in more complicated asthmatic children. A study in 2002 of infants and children reported lavage eosinophilia in atopic older children, and scant eosinophilia in younger children [28]. Both groups had elevated neutrophils. A 1999 report of 14 asthmatics by Marguet et al. revealed eosinophils in some of the asthmatics [17]. An Italian study in 2010 by Snijders et al. reported on 91 asthmatics, with a range of eosinophils on 0–29% and range of neutrophils of 0–91% [31]. In summary it should be expected for a complicated pediatric asthmatic to have recoverable neutrophils (including excessive) and a large range of eosinophils, but zero eosinophils is not unexpected.
The presence of eosinophils in up to 28% of our studied children was the most critical finding from the allergist’s perspective. When eosinophil(s) (or basophils or mast cells) is reported in a BAL differential, the possibility of asthma should be strongly entertained, even if it had not been considered before the lavage. This would offer the opportunity, at follow-up, to perform appropriate asthma/allergy testing, when available, a CBC and differential (eosinophil count), and allergy skin testing and age-appropriate PFT. As an example, if a BAL is performed with a pre-school male (less likely a female) with a food allergy, or atopic dermatitis, and who subsequently has one or more eosinophils on a BAL differential, asthma is highly likely, and appropriate asthma therapy considered.
It is recognized that other uncommon pediatric lung processes can have recoverable lavage eosinophilia [32], including drug-induced, acute eosinophilic pneumonia, infant pulmonary eosinophilia (PIE), parasite-induced Churg–Strauss syndrome, and atypical chronic PIE. None of these diagnoses were included in the 317 children but that does not exclude an eventual diagnosis of any of these listed conditions.
The secondary finding of high neutrophil counts, >50/100 cells, was an expected result, based on the literature of BAL in children with lung disease in this age group [22]. Coupled with a high rate of colony counts ≥ 100,000 bacteria, the neutrophilia suggests a discovered protracted bacterial bronchitis, regardless of the pre-BAL diagnosis [33]. Even when bronchitis was a BAL concern, all other groups without a “bronchitis” indication also tracked with high neutrophils and/or high bacterial cell counts. The use of recent pre-BAL antibiotics was not tracked in our protocol (IRB exclusion) but should be considered on future pre-BAL checklists in clinical practice. BAL eosinophilia did not track with high neutrophil/bacteria colony counts (Table 3) which suggests a different chemoattractant mechanism for each granulocyte [34].
LLM levels > 30 were used as a marker of potential micro aspirations, but in our population the finding of high LLM was more discoverable in non-aspiration BAL diagnosis children [35]. The presence of a proton pump inhibitor or H_2_ receptor antagonist should also be included on a pre-BAL check list.
6. Conclusions
Guided by an updated mini review of cellularity results obtained during BAL in normal control children from 1987 to 2023, the BAL results from an academic pulmonary (and allergy) division for the years 2000–2024 were reviewed post hoc. The evidence of a very high frequency of neutrophilia and culture positivity, far beyond the normative data of the review, was confirmation of an excessive likelihood of protracted bacterial bronchitis, as reported in previous studies [33]. Furthermore, the recoverability of eosinophils was discovered in at least 20% of children undergoing the procedure. The presence of this biomarker should assist with potential asthma/atopy considerations for longitudinal care decisions. Lipid-laden macrophage data was not confirmatory of suspected micro aspiration. The information obtained during a BAL investigation can direct further post-BAL testing and therapeutic decision making. It also suggests that a checklist of recent/current medications would provide a framework for explaining the results of the lavage cellularity and efficiently improve post-lavage therapeutic and diagnostic considerations.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1de Blic J. Midulla F. Barbato A. Clement A. Dab I. Eber E. Green C. Grigg J. Kotecha S. Kurland G. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children Eur. Respir. J.20001521723110.1183/09031936.00.1512170010678650 · doi ↗ · pubmed ↗
- 2Radhakrishnan D. Cory Yamashita C. Gillio-Meina C. Fraser D.D. Translational Research in Pediatrics III: Bronchoalveolar Lavage Pediatrics 201413413515410.1542/peds.2013-191124982109 · doi ↗ · pubmed ↗
- 3Januska M.N. Goldman D.L. Webley W. Teague W.G. Cohen R.T. Bunyavanich S. Vicencio A.G. Bronchoscopy in severe childhood asthma: Irresponsible or irreplaceable?Pediatr. Pulmonol.20205579580210.1002/ppul.2456931730298 PMC 7385726 · doi ↗ · pubmed ↗
- 4Lommatzsch M. Buhl R. Bergmann K.C. Canonica G.W. Jackson D.J. Eosinophils in asthma phenotypes: Perpetrators or guilty by association?Lancet Respir. Med.20251394395010.1016/S 2213-2600(25)00174-240645201 · doi ↗ · pubmed ↗
- 5Chang T.S. Lemanske R.F.Jr. Guilbert T.W. Gern J.E. Coen M.H. Evans M.D. Gangnon R.E. David Page C. Jackson D.J. Evaluation of the modified asthma predictive index in high-risk preschool children J. Allergy Clin. Immunol. Pract.2013115215610.1016/j.jaip.2012.10.00824187656 PMC 3811153 · doi ↗ · pubmed ↗
- 6Biagini Myers J.M. Schauberger E. He H. Martin L.J. Kroner J. Hill G.M. Ryan P.H. Le Masters G.K. Bernstein D.I. Lockey J.E. A Pediatric Asthma Risk Score to better predict asthma development in young children J. Allergy Clin. Immunol.201914318031810.e 210.1016/j.jaci.2018.09.03730554722 PMC 6504569 · doi ↗ · pubmed ↗
- 7Clement A. Chadelat K. Masliah J. Housset B. Sardet A. Grimfeld A. Tournier G. A controlled study of oxygen metabolite release by alveolar macrophages from children with interstitial lung disease Am. Rev. Respir. Dis.19871361424142810.1164/ajrccm/136.6.14242825568 · doi ↗ · pubmed ↗
- 8Ratjen F. Bredendiek M. Brendel M. Meltzer J. Costabel U. Differential cytology of bronchoalveolar lavage fluid in normal children Eur. Respir. J.199471865187010.1183/09031936.94.071018657828697 · doi ↗ · pubmed ↗
